X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (56) 56
index medicus (55) 55
oncology (40) 40
female (37) 37
aged (26) 26
middle aged (26) 26
male (22) 22
adult (20) 20
cancer (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
chemotherapy (13) 13
breast cancer (12) 12
breast neoplasms - drug therapy (10) 10
colorectal neoplasms - drug therapy (10) 10
prognosis (10) 10
research (10) 10
treatment outcome (10) 10
aged, 80 and over (9) 9
animals (9) 9
breast (9) 9
breast neoplasms - pathology (9) 9
care and treatment (9) 9
cancer patients (8) 8
cell biology (8) 8
colorectal cancer (8) 8
patients (8) 8
tumors (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
cetuximab (7) 7
drug resistance, neoplasm (7) 7
fluorouracil - administration & dosage (7) 7
hematology, oncology and palliative medicine (7) 7
immunohistochemistry (7) 7
neoplasms - drug therapy (7) 7
pharmacology & pharmacy (7) 7
risk factors (7) 7
time factors (7) 7
analysis (6) 6
antimitotic agents (6) 6
antineoplastic agents (6) 6
antineoplastic agents - therapeutic use (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
colorectal neoplasms - pathology (6) 6
deoxycytidine - analogs & derivatives (6) 6
gastrointestinal stromal tumors - drug therapy (6) 6
metastases (6) 6
metastasis (6) 6
organoplatinum compounds - administration & dosage (6) 6
settore med/06 - oncologia medica (6) 6
therapy (6) 6
antineoplastic agents - administration & dosage (5) 5
capecitabine (5) 5
cell line, tumor (5) 5
disease-free survival (5) 5
dose-response relationship, drug (5) 5
drug administration schedule (5) 5
gastrointestinal stromal tumors - pathology (5) 5
health aspects (5) 5
imatinib (5) 5
imatinib mesylate (5) 5
leucovorin - administration & dosage (5) 5
medical research (5) 5
medicine (5) 5
medicine & public health (5) 5
medicine, research & experimental (5) 5
mutation (5) 5
physiology (5) 5
prospective studies (5) 5
protein kinase inhibitors - administration & dosage (5) 5
research article (5) 5
survival (5) 5
1st-line treatment (4) 4
antibodies, monoclonal, humanized (4) 4
antineoplastic agents - pharmacology (4) 4
antineoplastic agents, hormonal - administration & dosage (4) 4
antineoplastic agents, hormonal - therapeutic use (4) 4
aromatase inhibitors - administration & dosage (4) 4
article (4) 4
bevacizumab (4) 4
biomarkers, tumor - genetics (4) 4
bone neoplasms - secondary (4) 4
breast neoplasms - genetics (4) 4
breast neoplasms - metabolism (4) 4
breast neoplasms - surgery (4) 4
camptothecin - analogs & derivatives (4) 4
cancers and neoplasms (4) 4
carcinoma (4) 4
cells (4) 4
chemotherapy, adjuvant - methods (4) 4
clinical trials as topic (4) 4
colorectal neoplasms - genetics (4) 4
deoxycytidine - administration & dosage (4) 4
disease progression (4) 4
drug therapy (4) 4
fluorouracil - adverse effects (4) 4
fluorouracil - analogs & derivatives (4) 4
fluorouracil - therapeutic use (4) 4
gastrointestinal stromal tumors (4) 4
gene-expression (4) 4
genetic aspects (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 06/2009, Volume 27, Issue 16, pp. 2622 - 2629
Purpose PTEN, AKT, and KRAS are epidermal growth factor receptor (EGFR) downstream regulators. KRAS mutations confer resistance to cetuximab. This... 
CELL LUNG-CANCER | PANITUMUMAB | K-RAS MUTATIONS | THERAPY | GROWTH-FACTOR-RECEPTOR | EFFICACY | ONCOLOGY | SIGNALING PATHWAY | RESISTANCE | EGFR | CHEMOTHERAPY | Immunohistochemistry | Predictive Value of Tests | ras Proteins - genetics | Phosphorylation | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | PTEN Phosphohydrolase - analysis | Drug Resistance, Neoplasm | Male | Patient Selection | Antibodies, Monoclonal, Humanized | Antineoplastic Agents, Phytogenic - administration & dosage | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Retrospective Studies | Cetuximab | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Colorectal Neoplasms - enzymology | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Treatment Outcome | Receptor, Epidermal Growth Factor - analysis | Protein Kinase Inhibitors - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins c-akt - analysis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Colorectal Neoplasms - secondary | Italy - epidemiology | Aged | Mutation | Longitudinal Studies | Index Medicus
Journal Article
Science Translational Medicine, ISSN 1946-6234, 08/2015, Volume 7, Issue 302, pp. 302ra133 - 302ra133
Journal Article
Journal Article
Nature Cell Biology, ISSN 1465-7392, 01/2015, Volume 17, Issue 1, pp. 81 - 94
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2011, Volume 6, Issue 4, pp. e19234 - e19234
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2007, Volume 25, Issue 10, pp. 1247 - 1254
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2018, Volume 24, Issue 15, pp. 3510 - 3518
Purpose: AZD9496 is an oral nonsteroidal, small-molecule inhibitor of estrogen receptor alpha (ER alpha) and a potent and selective antagonist and degrader of... 
ENDOCRINE RESISTANCE | TRIALS | FULVESTRANT 500 MG | THERAPY | ONCOLOGY | TAMOXIFEN | ESR1 MUTATIONS | MECHANISMS | POSTMENOPAUSAL WOMEN | INHIBITOR | Slopes | Tumor markers | Toxicity | Liver | Estrogens | Estrogen receptors | Diarrhea | Fatigue | Mass spectroscopy | Nausea | Breast cancer | Pharmacology | Patients | ErbB-2 protein | Anticancer properties | Safety engineering | Breast | Antitumor activity | Safety | Solid tumors | Mass spectrometry | Cancer | Tumors
Journal Article
Journal of the National Cancer Institute Monographs, ISSN 1052-6773, 5/2015, Volume 2015, Issue 51, pp. 4 - 8
Despite the ever-changing breast surgeon’s technical role, the surgeon forms an indispensible link between imaging, diagnostics, pathology, and the medical... 
Decision Making | Breast Neoplasms - surgery | Prognosis | Humans | Physician-Patient Relations | Breast Neoplasms - therapy | Chemotherapy, Adjuvant - methods | Neoadjuvant Therapy - methods | Surgeons | Female | Breast Neoplasms - diagnosis | Molecular Targeted Therapy - methods | Precision Medicine - methods | Physician's Role | Index Medicus
Journal Article
Nature Medicine, ISSN 1078-8956, 09/2018, Volume 24, Issue 9, pp. 1469 - 1480
Journal Article
16.